Evidence map›Paper›PMID 29462399›Full record

ArticleInflammatory bowel diseases2018

Mendelian Disease Associations Reveal Novel Insights into Inflammatory Bowel Disease.

Lichy Han, Mateusz Maciejewski, Christoph Brockel, Lovisa Afzelius, Russ B Altman

Open access · bronzeAbstract read
In one paragraph

Article in Inflammatory bowel diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Lichy HanBiomedical Informatics Training Program, Stanford University, Stanford, CA.
Mateusz MaciejewskiInflammation & Immunology, Pfizer Inc., Cambridge, MA.
Christoph BrockelHill's Pet Nutrition, Topeka KS.
Lovisa AfzeliusInflammation & Immunology, Pfizer Inc., Cambridge, MA.
Russ B AltmanBiomedical Informatics Training Program, Stanford University, Stanford, CA.
Pfizer (United States) · USStanford University · USHill Top Research (United States) · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007365 · NIGMS · STANFORD UNIVERSITY · PI CHUA, KATRIN F · 1985 to 2021
$33.8M
Undergraduate Summer Research Experiences Support for Combining systems biology and structural biology to find new therapeuticsR01GM102365 · NIGMS · STANFORD UNIVERSITY · PI ALTMAN, RUSS BIAGIO · 2012 to 2021
$3.0M
Systems Pharmacological Analysis of Drug Efficacy in Inflammatory Bowel DiseaseF30AI124553 · NIAID · STANFORD UNIVERSITY · PI HAN, LICHY · 2017 to 2019
$120k
NIAID NIH HHS F30 AI124553NIGMS NIH HHS R01 GM102365NIGMS NIH HHS T32 GM007365
6 · The paper itself

Abstract

Background: Monogenic diseases have been shown to contribute to complex disease risk and may hold new insights into the underlying biological mechanism of Inflammatory Bowel Disease (IBD). Methods: We analyzed Mendelian disease associations with IBD using over 55 million patients from the Optum's deidentified electronic health records dataset database. Using the significant Mendelian diseases, we performed pathway enrichment analysis and constructed a model using gene expression datasets to differentiate Crohn's disease (CD), ulcerative colitis (UC), and healthy patient samples. Results: We found 50 Mendelian diseases were significantly associated with IBD, with 40 being significantly associated with both CD and UC. Our results for CD replicated those from previous studies. Pathways that were enriched consisted of mainly immune and metabolic processes with a focus on tolerance and oxidative stress. Our 3-way classifier for UC, CD, and healthy samples yielded an accuracy of 72%. Conclusions: Mendelian diseases that are significantly associated with IBD may reveal novel insights into the genetic architecture of IBD.

Indexed as

Genetic Predisposition to DiseaseData MiningFemaleGene ExpressionGenetic Diseases, InbornHumansInflammatory Bowel DiseasesMaleRisk Factors

Identifiers

PMID29462399
PMCPMC6037048
OpenAlexW2789326774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.